Howard S Hochster, Associate Director for Clinical Research at Rutgers Cancer Institute of New Jersey, shared a post on X:
“Innovative biomarker driven trial in neoadjuvant therapy of gastric cancer. Thanks to PIs Dr Tim Kennedy and Dr Salma Jabbour. Presented at GI25. Thanks to all involved in this outstanding work and Merck for support.”